Trasylol Pulled From the Market

Recently Trasylol was pulled from the world wide market after the Canadian BART Study had to be haulted when alarmingly disproportionate numbers of patient being treated with Trasylol died when compare to with those being treated with similar, less expensive medications. The manufacturer of Trasylol, Bayer, has suspended worldwide marketing of Trasylol due to these overwhelming concerns. Some experts estimate that the use of Trasylol could be responsible for as many as 1,000 deaths per month.

Trasylol was commonly administered to patients during heart surgery to control blood loss, has been shown to cause adverse, and even fatal side effects. A study released in January of 2006 in the New England Journal of Medicine highlighted the adverse Trasylol side effects that were previously unknown by health professionals and heart surgery patients. Trasylol side effects that were found evident in an alarming pattern among patients included a significantly increased risk of heart attacks, strokes, kidney failure, and heart failure.

The study performed to examine Trasylol side effects was pioneered by Dr. Dennis T. Mangano of the Ischemia Research and Education Foundation and involved a sampling of 4374 heart surgery patients. The patients consisted people who were administered Trasylol, those who took generic options and others who took nothing, during their cardiovascular procedure. The results were unsettling.

Trasylol Side Effects:

Trasylol side effects pose and increased risk for heart attacks, strokes, kidney failure, and other serious cardiovascular complications. These side effects, in comparison with the generic options, resulted in a nearly doubled risk of renal failure, a 50 percent increased risk of heart attack and a 181 percent increased risk of stroke.

Medication Alternatives:

The results found in Dr. Mangano's and now the BART study support the use of alternative options to avoid Trasylol side effects. Many doctors and medical professionals involved in cardiovascular surgery admit to having been skeptical about Trasylol side effects far earlier than the release of the study. Effective alternatives for heart surgery blood clot medications are aminocaproic acid and tranexamic acid. In the research performed, aminocaproic acid and tranexamic acid proved to be just as effective, less costly, and significantly safer options than Trasylol.

If you or a loved on has been adversely affected by the use of Trasylol during surgery, you may be entitled to financial compensation for your pain and suffering. Contact us today to speak to an experienced personal injury attorney who is familiar with the legal rights of those injured by Trasylol.

You can contact Reich & Binstock by filling out the form on this page, by e-mail, or calling us toll free at 1-800-622-7271 for a free claim evaluation.